CelleksAlternative Names: Celleks
Latest Information Update: 30 Oct 2015
At a glance
- Originator Pharm-Sintez
- Mechanism of Action Cell death inhibitors; Cell differentiation stimulants; Growth factor receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Cerebrovascular disorders; Haemorrhage